A commonly used approach to improve recombinant protein production is to increase the levels of expression by providing extra-copies of a heterologous gene. In Komagataella phaffii (Pichia pastoris) this is usually accomplished by transforming cells with an expression vector carrying a drug-resistance marker following a screening for multicopy clones on plates with increasingly higher concentrations of an antibiotic. Alternatively, defective auxotrophic markers can be used for the same purpose. These markers are generally transcriptionally impaired genes lacking most of the promoter region. Among the defective markers commonly used in Saccharomyces cerevisiae is leu2-d, an allele of LEU2 which is involved in leucine metabolism. Cells transformed with this marker can recover prototrophy when they carry multiple copies of leu2-d in order to compensate the poor transcription from this defective allele. A K. phaffii strain auxotrophic for leucine (M12) was constructed by disrupting endogenous LEU2. The resulting strain was successfully transformed with a vector carrying leu2-d and an EGFP (enhanced green fluorescent protein) reporter gene. Vector copy numbers were determined from selected clones which grew to different colony sizes on transformation plates. A direct correlation was observed between colony size, number of integrated vectors and EGFP production. By using this approach we were able to isolate genetically stable clones bearing as many as 20 integrated copies of the vector and with no significant effects on cell growth. In this work we have successfully developed a genetic system based on a defective auxotrophic which can be applied to improve heterologous protein production in K. phaffii. The system comprises a K. phaffii leu2 strain and an expression vector carrying the defective leu2-d marker which allowed the isolation of multicopy clones after a single transformation step. Because a linear correlation was observed between copy number and heterologous protein production, this system may provide a simple approach to improve recombinant protein productivity in K. phaffii.
Komagataella phaffii (formerly Pichia pastoris) is a methylotrophic yeast widely used in laboratories around the world to produce recombinant proteins. Given its advantageous features, it has also gained much interest in the context of modern biotechnology. In this review, we present the utilization of K. phaffii as a platform to produce several products of economic interest such as biopharmaceuticals, renewable chemicals, fuels, biomaterials, and food/feed products. Finally, we present synthetic biology approaches currently used for strain engineering, aiming at the production of new bioproducts.
The term cellulase refers to any component of the enzymatic complex produced by some fungi, bacteria and protozoans which act serially or synergistically to catalyze the cleavage of cellulosic materials. Cellulases have been widely used in many industrial applications ranging from food industry to the production of second generation ethanol. In an effort to develop new strategies to minimize the costs of enzyme production we describe the development of a Pichia pastoris strain able to coproduce two different cellulases. For that purpose the eglII (endoglucanase II) and cbhII (cellobiohydrolase II) genes from Trichoderma reesei were fused in-frame separated by the self-processing 2A peptide sequence from the foot-and-mouth disease virus. The protein fusion construct was placed under the control of the strong inducible AOX1 promoter. Analysis of culture supernatants from methanol-induced yeast transformants showed that the protein fusion was effectively processed. Enzymatic assay showed that the processed enzymes were fully functional with the same catalytic properties of the individual enzymes produced separately. Furthermore, when combined both enzymes acted synergistically on filter paper to produce cellobiose as the main end-product. Based on these results we propose that P. pastoris should be considered as an alternative platform for the production of cellulases at competitive costs.
28 January 2022 in Biochemistry and Biophysics Reports
Immobilization of lipase from Burkholderia gladioli BRM58833 on octyl sepharose (OCT) resulted in catalysts with higher activity and stability. Following, strategies were studied to further stabilize and secure the enzyme to the support using functionalized polymers, like polyethylenimine (PEI) and aldehyde-dextran (DEXa), to cover the catalyst with layers at different combinations. Alternatively, the construction of a bifunctional layer was studied using methoxypolyethylene glycol amine (NH 2 -PEG) and glycine. The catalyst OCT-PEI-DEXa was the most thermostable, with a 263.8-fold increase in stability when compared to the control condition. When evaluated under alkaline conditions, OCT-DEXa-PEG 10 /Gly was the most stable, reaching stability 70.1 times greater than the control condition. Proportionally, the stabilization obtained for B. gladioli BRM58833 lipase was superior to that obtained for the commercial B. cepacia lipase. Preliminary results in the hydrolysis of fish oil demonstrated the potential of the coating technique with bifunctional polymers, resulting in a stable catalyst with greater catalytic capacity for the production of omega-3 PUFAs. According to the results obtained, it is possible to modulate B. gladioli BRM58833 lipase properties like stability and catalytic activity for enrichment of omega-3 fatty acids.
A espécie Cymbopogon densiflorus, conhecida popularmente como capim caboclo, capim nagô é tradicionalmente utilizada contra resfriados, asma e infecções é originária da África e bem aclimatada no Brasil. O objetivo deste trabalho foi identificar os principais compostos do óleo essencial da inflorescência de C. densiflorus e avaliar sua atividade antimicrobiana frente a microrganismos patogênicos humanos. O óleo foi obtido por hidrodestilação em aparelho Clevenger modificado por 2 h. As amostras foram caracterizadas por cromatografia gasosa e os principais compostos identificados foram monoterpenos, ésteres de ácido graxo, álcoois e óxidos, sendo o limoneno o constituinte presente em maior quantidade (13,07%). A análise da atividade microbiológica do óleo essencial em diferentes concentrações (100%, 50% e 25%) evidenciou sua capacidade antimicrobiana avaliada pela efetividade na inibição do crescimento dos microorganismos, Bacillus sp., S. aureus, E. coli indicado por meio da formação de halos de inibição do crescimento com diâmetro igual ou superior a 10 mm. Estudos futuros são requeridos a fim de se investigar o potencial terapêutico e econômico do óleo de C. densiflorus para o tratamento de doenças microbianas como pneumonia, infecçoes cutâneas, Gastroenterite, cistite que acometem a população.
The mevalonate pathway (MVA) is a central metabolic route responsible for the biosynthesis of isoprenoids, a vast and diverse class of biomolecules essential for cellular structure, signaling, and physiology. This review provides a comprehensive overview of the MVA pathway, addressing its distribution in different domains of life, evolutionary origins, and overall organization. We describe in detail its biochemical architecture, including enzymatic steps, catalytic mechanisms, structural characteristics, and multilayered regulatory strategies. In parallel, the methylerythritol phosphate pathway is presented as an alternative pathway to isoprenoid biosynthesis. The metabolic outputs of both pathways are explored, emphasizing the remarkable diversity of isoprenoid end products and their roles in membrane dynamics, protein modification, and cellular signaling. Furthermore, we analyze the biological functions and clinical relevance of the MVA pathway, including its involvement in human diseases and its variability in different kingdoms. The review also addresses recent advances in biotechnology, focusing on metabolic engineering and synthetic biology approaches for the microbial production of high-value isoprenoids. Finally, sustainable strategies for optimizing microbial cell factories and production processes are discussed, underscoring the growing importance of isoprenoid biosynthesis in industrial and pharmaceutical applications.